The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ublituximab plus TGR-1202 activity and safety profile in relapsed/refractory B-cell NHL and high-risk CLL.
 
Matthew Alexander Lunning
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Onyx; Spectrum Pharmaceuticals; TG Therapeutics
Research Funding - TG Therapeutics (Inst)
 
Julie Vose
Honoraria - Sanofi
Consulting or Advisory Role - Bank of America; Bio Connections; Foundation Medicine; KEW; Kite, a Gilead company; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); US Biotest (Inst)
Travel, Accommodations, Expenses - Foundation Medicine; Kite, a Gilead company
 
Nathan Hale Fowler
Consulting or Advisory Role - Celgene; Pharmacyclics; Roche Pharma AG; TG Therapeutics
Research Funding - Celgene (Inst); Pharmacyclics (Inst); Roche Pharma AG (Inst); TG Therapeutics (Inst)
 
Loretta J. Nastoupil
Research Funding - TG Therapeutics (Inst)
 
Marshall T. Schreeder
Research Funding - TG Therapeutics (Inst)
 
Tanya Siddiqi
Speakers' Bureau - Pharmacyclics
Research Funding - TG Therapeutics (Inst)
 
Christopher Flowers
Consulting or Advisory Role - Algeta ASA; OptumRx; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Other Relationship - Celgene
 
Jonathon Brett Cohen
Consulting or Advisory Role - Millennium; Pharmacyclics; Seagen
Research Funding - TG Therapeutics (Inst)
 
Susan Blumel
No Relationships to Disclose
 
Myra Miguel
No Relationships to Disclose
 
Warner H Tse
No Relationships to Disclose
 
Emily K. Pauli
Consulting or Advisory Role - TG Therapeutics
 
Kathy Cutter
No Relationships to Disclose
 
Peter Sportelli
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Hari P. Miskin
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Michael S. Weiss
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Swaroop V.S. Vakkalanka
Employment - Rhizen Pharmaceuticals
Leadership - Rhizen Pharmaceuticals
Stock and Other Ownership Interests - Rhizen Pharmaceuticals
 
Srikant Viswanadha
Employment - Incozen Therapeutics
Stock and Other Ownership Interests - Incozen Therapeutics
 
Susan Mary O'Brien
Consulting or Advisory Role - TG Therapeutics
Research Funding - TG Therapeutics (Inst)